Pages
(Move to ...)
Home
About me
▼
Showing posts with label
fatty liver
.
Show all posts
Showing posts with label
fatty liver
.
Show all posts
Tuesday, June 19, 2012
Merck Double-Knockdown Strategy to Ameliorate Toxicity from Mtp and ApoB Inhibition
›
The signs are that the next RNAi Therapeutics metabolic/cardiovascular disease candidate will be a dual-targeting one. While the initial...
4 comments:
Friday, August 19, 2011
Merck Seeks to Optimize Value of ApoB as Target for Hypercholesterolemia with Combinatorial RNAi Therapeutics
›
A series of recent papers (e.g. Ason et al. 1 ; Tadin-Strapps et al .; Ason et al. 2 ) shows that Merck wishes to use RNAi Therapeutics for ...
2 comments:
›
Home
View web version
